| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/15/1994 | US5294544 Biologically active factor |
| 03/15/1994 | US5294543 Inhibitor of platelet aggregation |
| 03/15/1994 | US5294538 Enzyme inhibitor |
| 03/15/1994 | US5294533 Detection of food poisoning bacteria, bacterial meningitis |
| 03/15/1994 | US5294451 Fat substitute compositions having reduced laxative effects |
| 03/15/1994 | US5294446 Composition and method of promoting hard tissue healing |
| 03/15/1994 | US5294430 Use of dithiocarbamates to treat myelosuppression |
| 03/15/1994 | CA1327869C Ribonucleotide reductase inhibitors |
| 03/15/1994 | CA1327867C Peptides suppressing the function of the immune system, pharmaceutical compositions containing them and process for preparing same |
| 03/15/1994 | CA1327800C Derivatives of aza-2-bicyclooctane-3-carboxylic acid, processes for their preparation and pharmaceutical compositions containing them |
| 03/15/1994 | CA1327747C Method of prevention or treatment of aids by inhibition of human immunodeficiency virus |
| 03/15/1994 | CA1327746C Method of treating fibrotic disorders |
| 03/15/1994 | CA1327745C Product containing as active ingredients : a) a peptide having a human immune interferon like activity, b) hydroxyurea |
| 03/13/1994 | CA2106038A1 Physiologically active peptide composition |
| 03/12/1994 | CA2105959A1 Aryl urea (thiourea) and cyanoguanidine derivatives |
| 03/10/1994 | DE4243496A1 New di:peptide neurokinin antagonists - useful in treating respiratory disorders, inflammatory eye and skin disorders, polyarthritis, osteoarthritis and pain |
| 03/10/1994 | DE4229879A1 Oxytocin as medicament for thyroid hypo= and hyper-function - in humans having none or insufficient oxytocin in the blood |
| 03/10/1994 | DE4229878A1 Oxytocin for treatment of juvenile type I diabetes mellitus - increases prodn of tyrosine and adrenalin, necessary for glycogen mobilisation |
| 03/10/1994 | DE4229707A1 Germicide Wirkstoffkombinationen Germicides drug combinations |
| 03/10/1994 | DE4229526A1 Transplant capsule comprising tissue or cells and oxygen carriers - to introduce e.g. insulin producing cells into human body; has long life span owing to internal oxygen supply |
| 03/10/1994 | CA2105612A1 Use of low doses of manganese superoxide dismutase (mn-sod) in the treatment of diseases |
| 03/09/1994 | EP0586303A1 Cosmetic or pharmaceutical composition containing an association between a peroxydase and an anti-singlet oxygen agent |
| 03/09/1994 | EP0586238A2 Method of producing sustained-release microcapsules |
| 03/09/1994 | EP0586094A1 Soluble LDL receptor and gene |
| 03/09/1994 | EP0586085A2 Veterinary method for the treatment of ketosis in livestock |
| 03/09/1994 | EP0586026A2 Characterization of a novel anti-p110 RB monoclonal antibody |
| 03/09/1994 | EP0585963A1 Monoclonal antibodies to CMP-170 antigen on activated endothelial cells |
| 03/09/1994 | EP0585957A1 Recombinant B-cell differentiation factor |
| 03/09/1994 | EP0585943A2 Soluble ligands for CD40 |
| 03/09/1994 | EP0585939A2 TNF ligands |
| 03/09/1994 | EP0585801A2 Bone-related cadherin-like protein and process for its production |
| 03/09/1994 | EP0585705A1 Use of anti-TNF to treat bacterial meningitis |
| 03/09/1994 | EP0585681A2 Use of IL-4 receptors for the therapy, prophylaxis and diagnosis of allergic, viral, paracitic and bacterial diseases, as well as of fungal infections |
| 03/09/1994 | EP0585631A1 Platelet-increasing agent |
| 03/09/1994 | EP0585570A1 Antigranulocyte antibody construct, preparation and use thereof |
| 03/09/1994 | EP0585552A1 Use of complement inhibitors for preparing a medicament for the prophylaxis and treatment of inflammatory intestinal and skin diseases as well as purpura |
| 03/09/1994 | EP0585444A1 Hepatoma treatment with somatostatin analogs |
| 03/09/1994 | EP0585415A1 Dna encoding a human 5-ht 1e? receptor and uses thereof |
| 03/09/1994 | EP0585412A1 Increasing blood-brain barrier permeability with permeabilizer peptides |
| 03/09/1994 | EP0585399A1 Treatment of colorectal carcinoma with antisense oligonucleotides to c-myb proto-oncogene |
| 03/09/1994 | EP0585398A1 Hcv genomic sequences for diagnostics and therapeutics |
| 03/09/1994 | EP0585384A1 Purification and cloning of p62 |
| 03/09/1994 | EP0585356A1 Cloning and expression of human islet glutamic acid decarboxylase autoantigen |
| 03/09/1994 | EP0585337A1 Method of suppressing tumor formation in vivo by administering je/mlp-1 |
| 03/09/1994 | EP0585257A1 Dna and amino acid sequence specific for natural killer cells |
| 03/09/1994 | EP0585242A1 Wound healing |
| 03/09/1994 | EP0585224A1 MONOCLONAL ANTIBODIES WHICH BIND TO SECRETED AND MEMBRANE-BOUND IgE, BUT NOT TO IgE ON BASOPHILS |
| 03/09/1994 | EP0439544B1 In vivo neurotrophic cytoprotective alcohols |
| 03/09/1994 | EP0437487B1 Targetting agents |
| 03/09/1994 | EP0420914B1 Cosmetic and skin treatment compositions |
| 03/09/1994 | EP0383751B1 Production of human parathyroid hormone from microorganisms |
| 03/09/1994 | CN1083485A Benzothiazepine and benzoxazepine derivatives |
| 03/09/1994 | CN1083391A Teeth nursing agentia |
| 03/09/1994 | CN1083390A Wound nursing agent |
| 03/09/1994 | CN1083389A A novel anti-neoplastic cytokine |
| 03/09/1994 | CN1083361A Antitoxic antiseptic oral liquor |
| 03/08/1994 | US5292867 Chimeric monoclonal antibodies which bind to the extracellular segment of the membrane-bound domain of a human membrane-bound immunoglobulin |
| 03/08/1994 | US5292802 Collagen-polymer tubes for use in vascular surgery |
| 03/08/1994 | US5292724 Intraocular anticoagulant including antithrombin III and method of administration |
| 03/08/1994 | US5292723 Liquid nutritional compositions comprising slowly absorbed glucides |
| 03/08/1994 | US5292721 Use of growth hormone to enhance porcine fetal energy and sow lactation performance |
| 03/08/1994 | US5292667 Detection and treatment of ulcerative colitis |
| 03/08/1994 | US5292662 Position-specific insertion vectors and method of using same |
| 03/08/1994 | US5292642 Methods and compositions for the detection of monocyte cytotoxicity inducing factor |
| 03/08/1994 | US5292512 Cosmetic or pharmaceutical composition containing microspheres of polymers or of fatty substances filled with at least one active product |
| 03/08/1994 | US5292510 WS7622A mono- or di- sulfate, process for preparation thereof and use thereof |
| 03/08/1994 | US5292509 Method for the disinsertion of vitreous body by an enzyme which disrupts or degrades chondroitin sulfate proteoglycan |
| 03/08/1994 | US5292506 Muramyldipeptide derivatives and influenza vaccine comprising the derivatives |
| 03/08/1994 | US5292499 Method of preparing medical aerosol formulations including drug dissolved in reverse micelles |
| 03/08/1994 | US5292362 Tissue bonding and sealing composition and method of using the same |
| 03/08/1994 | CA1327674C Method and apparatus for separating proteins |
| 03/08/1994 | CA1327566C Brain-specific drug delivery |
| 03/04/1994 | CA2470670A1 Tnf ligands |
| 03/03/1994 | WO1994004927A1 Method for diagnosing and monitoring sepsis |
| 03/03/1994 | WO1994004923A1 Immunoglobulin associated molecules on b cells defined by monoclonal antibodies |
| 03/03/1994 | WO1994004704A1 Effects of actin filaments on fibrin clot structure and lysis |
| 03/03/1994 | WO1994004702A2 Improved detection and therapy of lesions with biotin/avidin conjugates |
| 03/03/1994 | WO1994004698A1 Novel protein and gene coding for the same |
| 03/03/1994 | WO1994004697A1 Novel elafin derivative |
| 03/03/1994 | WO1994004696A1 Translocation signal facilitated nuclear delivery of macromolecules |
| 03/03/1994 | WO1994004691A2 Dimer and multimer forms of single chain polypeptides |
| 03/03/1994 | WO1994004690A1 Bispecific immunoadhesins |
| 03/03/1994 | WO1994004689A1 Recombinant toxin with increased half-life |
| 03/03/1994 | WO1994004688A2 Cationic peptides and method for production |
| 03/03/1994 | WO1994004686A1 Tat-derived transport polypeptides |
| 03/03/1994 | WO1994004680A1 Human interleukin-13 |
| 03/03/1994 | WO1994004679A1 Method for making humanized antibodies |
| 03/03/1994 | WO1994004677A1 The use of cd4 plasma membrane vesicles (pmv) as a therapeutic agent for aids |
| 03/03/1994 | WO1994004676A1 Stress protein epitopes |
| 03/03/1994 | WO1994004675A2 Dna sequence encoding a novel member of the steroid and thyroid hormone receptor family |
| 03/03/1994 | WO1994004674A1 Human melanocyte stimulating hormone receptor |
| 03/03/1994 | WO1994004671A1 Methods and therapeutic compositions for treating cystic fibrosis |
| 03/03/1994 | WO1994004670A1 Use of the cytokine ip-10 as an anti-tumor agent |
| 03/03/1994 | WO1994004669A1 Mice having cftr defect as model for cystic fibrosis |
| 03/03/1994 | WO1994004667A1 Targeted replacement of a gene without endogenous and selectable residual sequences |
| 03/03/1994 | WO1994004659A1 A novel b-lymphoma cell line and antigen |
| 03/03/1994 | WO1994004658A1 Methods for maturing precursor b cells |
| 03/03/1994 | WO1994004574A1 Hiv immunotherapeutics |
| 03/03/1994 | WO1994004571A1 A substrate for the epidermal growth factor receptor kinase |
| 03/03/1994 | WO1994004570A1 Cd40 ligand, anti cd40 antibodies, and soluble cd40 |